Langerhans cell histiocytosis

Rare Hematological Malignancies

Volumn , Issue , 2008, Pages 383-398

  Chang, Karen L ^a   Snyder, David S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIOCYTOSIS X; HUMAN; REVIEW;

HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS;

EID: 40549131347     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-73744-7_17     Document Type: Chapter

References (76)

1. Coppes-Zantinga A, Egeler RM. The Langerhans cell histiocytosis X files revealed. Br J Haematol 2002;116:3-9.
2. Favara BE, Feller AC, Paulli M, et al. A contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassfication Working Group of the Histiocyte Society. Med Pediatr Oncol 1997;29:157-166.
3. Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987; i: 209.
4. Lieberman PH, Jones CR, Steinman RM, et al. Langerhans cell (eosinophilic) granulomatosis: a clinicopathologic study encompassing 50 years. Am J Surg Pathol 1996;20:519-552.
5. Nezelof C, Basset F. Langerhans cell histiocytosis research; past, present, and future. Hematol Oncol Clin North Am 1998;12:385-406.
6. Lichtenstein L. Lichtenstein L. Histiocytosis X: integration of eosinophilic granuloma of bone, Letterer-Siwe disease and Schüller- Christian disease as related manifestations of a single nosologic entity. Arch Pathol 1953;56:84-102.
7. Baumgartner I, von Hochstetter A, Baumert B, et al. Langerhans'-cell histiocytosis in adults. Med Pediatr Oncol 1997;28:9-14.
8. Nicholson HS, Egeler RM, Nesbit ME. The epidemiology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:379-384.
9. Howarth DM, Gilchrist GS, Mullan BP, et al. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999;85:2278-2290.
10. Arico M, Girschikofsky M, Genereau T, et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 2003;39:2341-2348.
11. Mickelson MR, Bonfiglio M. Eosinophilic granuloma and its variations. Orthop Clin North Am 1997;8:933-945.
12. Winkelmann RK. The skin in histiocytosis X. Mayo Clin Proc 1969;44:535-548.
13. Alessi DM, Maceri D. Histiocytosis X of the head and neck in a pediatric population. Arch Otolaryngol Head Neck Surg 1992;118:945-948.
14. Colby TV, Lombard C. Histiocytosis X in the lung. Hum Pathol 1983;14:847-856.
15. Katz AM, Rosenthal SD, Jakubovic HR, et al. Langerhans cell histiocytosis in monozygotic twins. J Amer Acad Dermatol 1991;24:32-37.
16. Hanapiah F, Yaacob H, Ghani KS, et al. Histiocytosis X: evidence for a genetic etiology. J Nihon Univ Sch Dent 1993;35:171-174.
17. Arico M, Nichols K, Whitlock JA, et al. Familial clustering of Langerhans cell histiocytosis. Br J Haematol 1999;107:883-888.
18. Geissmann F, Lepelletier Y, Fraitag S, et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001;97:1241-1248.
19. McClain KL. Langerhans cell histiocytosis: what is the orphan telling us? Am Soc Hematol Educ Program Book 2004; xx: 284-295.
20. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (Histiocytosis X): a clonal proliferative disease. N Engl J Med 1994;331:154-160.
21. Yu RC, Chu C, Buluwela L, et al. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994;343:767-768.
22. Leahy MA, Krejci SM, Friedmash M, et al. Human herpsvirus 6 is present in lesions of Langerhans cell histiocytosis. J Invest Dermatol 1993;101:642-645.
23. Chen C-J, Ho T Y, Lu JJ, et al. Identical twin brothers concordant for Langerhans' cell histiocytosis and discordant for Epstein-Barr virus-associated haemophagocytic syndrome. Eur J Pediatr 2004;163:539.
24. McClain K, Jin H, Gresik V, et al. Langerhans cell histiocytosis: lack of a viral etiology. Am J Hematol 1994;47:16-20.
25. Murakami I, Gogusev J, Fournet JC, et al. Detection of molecular cytogenetic aberrations in Langerhans cell histiocytosis of bone. Hum Pathol 2002;33:555-560.
26. Betts DR, Leibundgut KE, Feldges A, et al. Cytogenetic abnormalities in Langerhans cell histiocytosis. Br J Cancer 1998;77:552-555.
27. Scappaticci S, Danesino C, Rossi E, et al. Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langerhans cell histiocytosis. Br J Haematol 2000;111:258-262.
28. Surico G, Muggeo P, Rigillo N, et al. Concurrent Langerhans cell histiocytosis and myelodysplasia in children. Med Pediatr Oncol 2000;35:434-438.
29. Lavabre-Bertrand T, Bourquard P, Chiesa J, et al. Diabetes insipidus revealing acute myelogenous leukaemia with a high platelet count, monosomy 7 and abnormalities of chromosome 3: a new entity? Eur J Haematol 2006;66:66-69.
30. Brescia M, Petti MC, Ottaviani E, et al. Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role? Br J Haematol 2001;118:438-441.
31. Vassalo R, Ryu JH, Colby T V, et al. Pulmonary Langerhan's-cell histiocytosis. N Eng J Med 2000;342:1969-1978.
32. Yousem SA, Colby T V, Chen Y Y, et al. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001;25:630-636.
33. Egeler RM, Neglia JP, Arico M, et.al. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am 1998;12:369-378.
34. Burns BF, Colby TV, Dorfman RF. Langerhans' cell granulomatosis (histiocytosis X) associated with malignant lymphomas. Am J Surg Pathol 1983;7:529-533.
35. Egeler RA, Neglia JP, Puccetti DM, et al. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 1993;71:865-873.
36. Egeler RM, Neglia JP, Arico M, et al. Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol 1994;23:81-85.
37. Neuman MP, Frizzera G. The coexistence of Langerhans' cell granulomatosis and malignant lymphoma may take different forms: Report of seven cases with a review of the literature. Hum Pathol 1986;17:1060-1065.
38. Nezelof C, Basset F. An hypothesis Langerhans cell histiocytosis: the failure of the immune system to switch from an innate to an adaptive mode. Pediatr Blood Cancer 2004;42:398-400.
39. Egeler RM, Favara BE, van Meurs M, et al. Differential in situ cytokine profiles of Langerhanslike cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 1999;94:4195-4201.
40. Annels NE, da Costa CE, Prins FA, et al. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med 2003;197:1385-1390.
41. Stockschlaeder M, Sucker C. Adult Langerhans cell histiocytosis. Eur J Haematol 2006;76:363-368.
42. Gadner H, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001;138:734.
43. Savasan S. An enigmatic disease: childhood Langerhans cell histiocytosis in 2005. Int J Dermatol 2006;45:182-188.
44. Maghie M, Cosi G, Genovese E, et al. Central diabetes insipidus in children and young adults. N Eng J Med 2000;343:998-1007.
45. Di Maggio LA, Lippes HA, Lee RV. Histiocytosis X and pregnancy. Obstet Gynecol 1995;85:806-809.
46. Braunstein GD, Kohler PO. Endocrine manifestations of histiocytosis. Am J Pediatr Hematol Oncol 1981;3:67-75.
47. Munn S, Chu AC. Langerhans cell histiocytosis of the skin. Hematol Oncol Clin North Am 1998;12:269-286.
48. Motoi M, Helbron D, Kaiserling E, et al. Eosinophilic granuloma of lymph nodes: a variant of histiocytosis X. Histopathology 1980;4:585-606.
49. Scherbaum WA, Seif FJ. Spontaneous transient remission of disseminated histiocytosis X during pregnancy. J Cancer Res Clin Oncol 1995;121:57-60.
50. Vassallo R, Ryu JH, Schroeder DR, et al. Pulmonary Langerhans'-cell histiocytosis. N Eng J Med 2002;346:484-490.
51. Travis W, Borok Z, Roum JH, et al. Pulmonary Langerhans' cell granulomatosis (Histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 1993;17:971-986.
52. Brauner MW, Greiner P, Mouelhi MM, et al. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989;172:255-258.
53. Chang KL, Gaal KK, Huang Q, et al. Histiocytic lesions involving the bone marrow. Semin Diagn Pathol 2003;20:226-236.
54. Crausman RS, Jennings CA, Tuder RM, et al. Pulmonary histiocytosis X: Pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 1996;153:426-435.
55. Nezelof C, Frileux-Herbet F, Cronier-Sachot J. Disseminated histiocytosis X. Analysis of prognostic factors based on a retrospective study of 50 cases. Cancer 1979;44:1824-1838.
56. Favara BE, Jaffe R. Pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1987;1:75-97.
57. Birbeck M, Breahnach A. An electron microscopy study of basal melanocytes and high-level clear cells (Langerhans Cells) in vitiligo. J Invest Dermatol 1961;37:51-63.
58. Valladeau J, Dezutter-Dambuyant C, Saeland S. Langerin/CD207 sheds light on formation of birbeck granules and their possible function in Langerhans cells. Immunol Res 2003;28:93-107.
59. Chikwava K, Jaffe R. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. Pediatr Dev Pathol 2004;7:607-614.
60. Chu PG, Chang KL, Arber DA, Weiss LM. Practical applications of immunohistochemistry for hematolymphoid disorders: an updated review. Ann Diagn Pathol 1999;3:104-133.
61. Ruco LP, Pulford K A F, Mason D. Expression of macrophage-associated antigens in tissues involved by Langerhans' cell histiocytosis (histiocytosis X). Am J Clin Pathol 1989;92:273-279.
62. Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol 2004;122:794-801.
63. Yu RC, Chu AC. Lack of T-cell receptor gene rearrangements in cells involved in Langerhans cell histiocytosis. Cancer 1995;75:1162-1166.
64. Foucar K, Foucar E. The mononuclear phagocyte and immunoregulatory effector (M-PIRE) system: evolving concepts. Semin Diagn Pathol 1990;7:4-18.
65. Ceci A, de Terlizzi M, Collela R, et al. Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H. X 83 study. Med Pediatr Oncol 1993;21:259-264.
66. Titgemeyer C, Grois N, Minkov M, et al. Pattern and course of single-system disease in Langerhans cell histiocytosis. Data from the DAL-HX83- and 90-study. Med Pediatr Oncol 2001;37:108-114.
67. Smith MA, Rubenstein L, Anderson JR, et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 1999;17:569-577.
68. Krishnan A, Bhatia S, Slovak ML, et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 2000;95:1588-1593.
69. Seegenschmiedt HM, Micke O, Olschewski T, et al. Radiotherapy is effective in symptomatic Langerhans cell hsitiocytosis (LCH): long-term results of a multicenter study in 63 patients. Int J Radiat Oncol Biol Phys 2003;57(Suppl. 2):S251.
70. Stine KC, Saylors RL, Saccente S, et al. Efficacy of continuous infusion 2-CDA (Cladribine) in pediatric patients with Langerhans cell histiocytosis. Pediatr Blood Cancer 2004;43:81-84.
71. Kinugawa N, Imashuku S, Hirota Y, et al. Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan. Bone Marrow Transplant 1999;24:935-938.
72. Akkari V, Donadieu J, Piguet C, et al. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant 2003;31:1097-1103.
73. Steiner M, Matthes-Martin S, Attarbaschi A, et al. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reducedintensity conditioning. Bone Marrow Transplant 2005;36:215-225.
74. Kelly KM, Beverley PC, Chu AC, et al. Successful in vivo immunolocalization of Langerhans cell histiocytosis with use of a monoclonal antibody, NA1/34. J Pediatr 1994;125:717-722.
75. Jordan MB, McClain KL, Yan X, et al. Anti-CD52 antibody, alemtuzumab, binds to Langerhans cells in Langerhans cell histiocytosis. Pediatr Blood Cancer 2005;44:251-254.
76. Haupt R, Nanduri V, Calevo MG, et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 2004;42:438-444.